CS logo
small CS logo
Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz

Mainz, Rheinland-Pfalz, Germany

About Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


During the past decade, Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Alzheimer Forschungsinitiative e.V. (AFI)" with 1 trials as a collaborator, "Anavex Canada Ltd." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


According to Clinical.Site data, the most researched conditions in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" are "Alzheimer Disease" (3 trials) and "Alcohol Dependence" (1 trials). Many other conditions were trialed in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" in a lesser frequency.

Clinical Trials Intervention Types at Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


Most popular intervention types in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ANAVEX2-73" (1 trials), "Acitretin" (1 trials), "High dose ANAVEX2-73" (1 trials) and "Mid dose ANAVEX2-73" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


The vast majority of trials in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz" are 4 trials for "All" genders.

Clinical Trials Status at Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz


Currently, there are NaN active trials in "Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of psychiatry and psychotherapy, University medical center of the Johannes Gutenberg-University Mainz, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".